Aura Biosciences CEO Elisabet de los Pinos sells $98,787 in inventory By Investing.com
BOSTON—Elisabet de los Pinos, President and CEO of Aura Biosciences, Inc. (NASDAQ:AURA),…
By
Tycoon Herald
5 Min Read
IDEAYA Biosciences Proclaims IND-Clearance for Werner Helicase Improvement Candidate IDE275 (GSK959) for a Part 1 Examine in MSI-Excessive Stable Tumors By Investing.com
IDE275 (GSK959) growth is progressing into First-in-Human Part 1 scientific trial(s) for…
By
Tycoon Herald
7 Min Read
Precision BioSciences to Take part in Upcoming Longwood Boston CEO and Guggenheim Healthcare Conferences By Investing.com
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a medical stage gene enhancing…
By
Tycoon Herald
2 Min Read
Avidity Biosciences CEO sells over $1.4 million in firm inventory By Investing.com
In a latest transaction, Sarah Boyce, the President and CEO of Avidity…
By
Tycoon Herald
6 Min Read
IGM Biosciences CEO sells shares value over $45,000 By Investing.com
IGM Biosciences, Inc. (NASDAQ:) CEO and President Fred Schwarzer has offered a…
By
Tycoon Herald
6 Min Read
BofA flags investor doubts as Arcus Biosciences inventory struggles By Investing.com
On Friday, BofA Securities revised its worth goal for Arcus Biosciences (NYSE:),…
By
Tycoon Herald
6 Min Read
Senhwa Biosciences receives US FDA Examine Might Proceed letter for the Part I/II examine of Silmitasertib (CX-4945) together with chemotherapy in kids and younger adults with relapsed refractory s By Investing.com
TAIPEI and SAN DIEGO, Aug. 6, 2024 /PRNewswire/ -- Senhwa Biosciences, Inc.…
By
Tycoon Herald
2 Min Read
Tyra Biosciences hits 52-week excessive, reaching $21.67 By Investing.com
Tyra Biosciences, a number one biotechnology firm, has reached a brand new…
By
Tycoon Herald
4 Min Read